The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
Autor: | Khan Y; Department of Public Health and Primary Care, Ghent University, Ghent 9000, Belgium.; Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium.; Department of Sociology, Interface Demography, Vrije Universiteit Brussel, Brussels 1050, Belgium., Verhaeghe N; Department of Public Health and Primary Care, Ghent University, Ghent 9000, Belgium.; Research Institute for Work and Society, KU Leuven, Leuven 3000, Belgium.; Department of Rehabilitation Sciences, Ghent University, Ghent 9000, Belgium., Devleesschauwer B; Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium.; Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke 9000, Belgium., Cavillot L; Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium.; Research Institute of Health and Society, University of Louvain, Brussels 1200, Belgium., Gadeyne S; Department of Sociology, Interface Demography, Vrije Universiteit Brussel, Brussels 1050, Belgium., Pauwels N; Faculty of Medicine, Ghent University, Ghent 9000, Belgium., Van den Borre L; Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium.; Department of Sociology, Interface Demography, Vrije Universiteit Brussel, Brussels 1050, Belgium., De Smedt D; Department of Public Health and Primary Care, Ghent University, Ghent 9000, Belgium. |
---|---|
Jazyk: | angličtina |
Zdroj: | European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2023 Nov 02; Vol. 9 (7), pp. 647-661. |
DOI: | 10.1093/ehjqcco/qcad051 |
Abstrakt: | Aims: Cardiovascular diseases (CVD) are the leading cause of death worldwide. The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare systems, causing delays in essential medical services, and potentially impacting CVD treatment. This study aims to estimate the impact of the pandemic on delayed CVD care in Europe by providing a systematic overview of the available evidence. Methods and Results: PubMed, Embase, and Web of Science were searched until mid-September 2022 for studies focused on the impact of delayed CVD care due to the pandemic in Europe among adult patients. Outcomes were changes in hospital admissions, mortality rates, delays in seeking medical help after symptom onset, delays in treatment initiation, and change in the number of treatment procedures. We included 132 studies, of which all were observational retrospective. Results were presented in five disease groups: ischaemic heart diseases (IHD), cerebrovascular accidents (CVA), cardiac arrests (CA), heart failures (HF), and others, including broader CVD groups. There were significant decreases in hospital admissions for IHD, CVA, HF and urgent and elective cardiac procedures, and significant increases for CA. Mortality rates were higher for IHD and CVA. Conclusion: The pandemic led to reduced acute CVD hospital admissions and increased mortality rates. Delays in seeking medical help were observed, while urgent and elective cardiac procedures decreased. Adequate resource allocation, clear guidelines on how to handle care during health crises, reduced delays, and healthy lifestyle promotion should be implemented. The long-term impact of pandemics on delayed CVD care, and the health-economic impact of COVID-19 should be further evaluated. (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.) |
Databáze: | MEDLINE |
Externí odkaz: |